Correspondence Address:
Dr. Nikita Rathee PG Scholar, Department of PG Studies in Kayachikitsa, Sri Kalabyraveshwara Swamy Ayurvedic Medical College, Hospital and Research Centre, Vijayanagar, Bengaluru. Email- nikitarathee25011@gmail.com Mobile no: - 7015481142
Date of Acceptance: 2025-12-13
Date of Publication:2026-01-03
Article-ID:IJIM_489_01_26 https://ijim.co.in
Source of Support: Nill
Conflict of Interest: Non declared
How To Cite This Article: Rathee N., Adiga M. Integrative Ayurvedic Management of Metabolic Disorder with Autoimmune Comorbidity: A Case Study. Int J Ind Med 2025;6(12):43-50 DOI: http://doi.org/10.55552/IJIM.2025.61207
Introduction: Metabolic disorders constitute a heterogeneous group of conditions arising from disturbances in carbohydrate and lipid metabolism, commonly presenting as obesity, type 2 diabetes mellitus, dyslipidaemia, and hypertension. These disorders frequently coexist with autoimmune diseases such as rheumatoid arthritis due to shared mechanisms including chronic inflammation, oxidative stress, and immune dysregulation. Conventional long-term pharmacological management often leads to polypharmacy with limited improvement in overall quality of life. Ayurveda offers a holistic and individualized approach by correcting impaired metabolic function (Agnimandya), eliminating metabolic toxins (Ama), and restoring Dosha–Dhatu–Mala balance, thereby addressing the root pathology in complex multisystem disorders. Aim and Objectives: To evaluate the role of integrative Ayurvedic management in achieving metabolic balance, reducing drug dependency, and improving quality of life in a patient with metabolic disorder and autoimmune comorbidity. Materials and Methods: A 44-year-old female with obesity, type 2 diabetes mellitus, hypothyroidism, hypertension, and RA underwent integrative Ayurvedic management for five months, including Panchakarma therapies, Shamana and Rasayana medications, diet and lifestyle modification, alongside essential allopathic medications. Results: Significant improvement was observed in body weight, BMI, glycaemic status, thyroid profile, joint pain, stiffness, and energy levels. Reduction and discontinuation of antidiabetic drugs, analgesics, hydroxychloroquine, and DMARDs were achieved under medical supervision. WHOQOL-BREF and RAPID-3 scores showed marked improvement.
Conclusion: Integrative Ayurvedic management effectively complemented conventional therapy in a complex metabolic–autoimmune condition by correcting Agni, Ama, and Medodoshaja pathology, reducing polypharmacy and improving quality of life.
Keywords: Metabolic disorder, Integrative Ayurveda, Rheumatoid Arthritis, Amavata, Agni, Ama, Panchakarma.